Literature DB >> 15370720

Pulmonary hypertension in rheumatoid arthritis.

G Keser1, I Capar, K Aksu, V Inal, Z Danaoğlu, R Savas, F Oksel, E Tunc, Y Kabasakal, G Kitapcioglu, E Doganavsargil.   

Abstract

Using Doppler echocardiography (DE), we measured pulmonary arterial systolic pressure (PASP) in rheumatoid arthritis (RA) patients without coexisting cardiopulmonary diseases. Accepting the normal upper limit of PASP as 30 mmHg, we found elevated PASP in 11 out of 40 (27.5%) RA patients, values being mostly 30-40 mmHg, indicating mild pulmonary hypertension (PHT). Although estimation of PASP by DE is not as reliable as cardiac catheterisation, it is possible that mild elevations in PASP may contribute to the high incidence of cardiovascular events not explained by traditional cardiac risk factors in patients with RA. Long-term follow-up will be obviously necessary to ascertain the impact of mild PHT on the prognosis and mortality rate of RA patients.

Entities:  

Mesh:

Year:  2004        PMID: 15370720     DOI: 10.1080/03009740410005809

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

Review 1.  [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases].

Authors:  A Hagendorff; D Pfeiffer
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

2.  Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Jorge A Zamora-Legoff; Megan L Krause; Cynthia S Crowson; Jay H Ryu; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2017-03       Impact factor: 10.995

3.  Increased prevalence of diastolic dysfunction in rheumatoid arthritis.

Authors:  Kimberly P Liang; Elena Myasoedova; Cynthia S Crowson; John M Davis; Véronique L Roger; Barry L Karon; Daniel D Borgeson; Terry M Therneau; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

4.  [Clinical and immunological characteristics of 88 cases of overlap myositis].

Authors:  Y S Xiao; F Y Zhu; L Luo; X Y Xing; Y H Li; X W Zhang; D H Shen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

Review 5.  Treatment of pulmonary arterial hypertension in connective tissue disease.

Authors:  Ekkehard Grünig
Journal:  Drugs       Date:  2012-05-28       Impact factor: 11.431

Review 6.  Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.

Authors:  Jon T Giles; Verônica Fernandes; Joao A C Lima; Joan M Bathon
Journal:  Arthritis Res Ther       Date:  2005-08-24       Impact factor: 5.156

Review 7.  Connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Robin Condliffe; Luke S Howard
Journal:  F1000Prime Rep       Date:  2015-01-05

Review 8.  Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.

Authors:  Xiaoqin Yang; Jack Mardekian; Kafi N Sanders; Marko A Mychaskiw; Joseph Thomas
Journal:  Clin Rheumatol       Date:  2013-06-20       Impact factor: 2.980

Review 9.  Thoracic Manifestations of Rheumatoid Arthritis.

Authors:  Anthony J Esposito; Sarah G Chu; Rachna Madan; Tracy J Doyle; Paul F Dellaripa
Journal:  Clin Chest Med       Date:  2019-07-06       Impact factor: 4.967

10.  Pulmonary Arterial Hypertension in Patients with Primary Sjögren's Syndrome.

Authors:  Senol Kobak; Sezai Kalkan; Bahadır Kirilmaz; Mehmet Orman; Ertuğurul Ercan
Journal:  Autoimmune Dis       Date:  2014-01-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.